u/lina_bruun

protein and resistance training, that is the entire intervention

Kept a log specifically because there is so little published. It is one person and it is not data.

phase 2 data only, and people quote it like it is a label

Stopped at a low step because there was no reason to go further and no data to tell me what further would do.

Careful with the rankings. A phase 2 result and a phase 3 result are not on the same evidential footing and cannot be listed in one table.

Yes — nobody here is your clinician, and the good answers on this board all end with that.

Same. The injection was the thing I was most nervous about and the thing that turned out to matter least.

I would not read a supply notice as a shortage in your pharmacy tomorrow. They are not the same thing.

Read the MHRA notice rather than the news coverage and the actual scope was much narrower than the panic threads suggested.

not approved anywhere, which is the single most important fact in this board

What is the source for that figure — the published paper or a summary of it?

Is this a shop, a group buy, or an individual reseller? They fail in different ways.

That comparison is between two different products at two different concentrations, which is where the confusion is coming from.

That is area percent from a certificate, not the amount of peptide in the vial. Two different numbers and a very common mix-up.

What week are you in?

Asked what a COA was in my first week. Somebody linked the explainer and I have been reading them ever since.

Group buys concentrate custody, payment and communication in one person with no structure behind it.

Disagreeing here: that is a delay, and this board has to keep delay and intent in separate columns.

Independent purity testing on this compound is thin compared with the older molecules, simply because fewer members have paid for it. Fewer results means wider uncertainty, not a verdict.

heart rate is the thing people report watching

A certificate of analysis is a document describing one batch: what was tested, by what method, and what the result was. Its value depends entirely on whether it names the batch and the method.

Tracked grip strength and three lifts monthly. Cheaper than scanning and directionally the same answer.

phase 3 is where the comparison becomes fair

Some lean mass loss accompanies weight loss in any deficit.

Agreed — and same machine, same conditions, or the two scans are not comparable.

Lost money once, years ago, to a shop that pushed hard for a decision the same day. Every time I see that pressure now I close the tab.

a lot of the confident posting here is extrapolation

Correction: those scans are from different machines, and the difference you are describing is within the measurement error.

DEXA has a real error margin and people quote it to one decimal

Small correction, said kindly: those are two different products with similar names, and the difference matters for a multi-draw vial.

I confused two very similar words on my first order and asked here, expecting to be mocked.

Adding the one habit worth starting today: write the concentration on the vial.

Cosigning that protein gets harder precisely when appetite drops. That is the actual difficulty and it is logistical.

How fast was the escalation? That is usually the variable that explains the reports.

It is a non-peptide small-molecule agonist at the GLP-1 receptor. That is a substantial medicinal chemistry achievement: getting a small molecule to activate a receptor evolved for a peptide ligand.

Four pharmacies, four prices, same product, same month. The spread was larger than I expected and none of them were the headline offer.

BMI thresholds vary by ICB and by year

Agreed — and keeping the letters with dates is what makes any later challenge possible.

Small fix — that is the Scottish pathway. The post is asking about England and the answer is different.

Did the consultation ask about history and medication?